A.I. Pioneer Issues Urgent Warning to Americans
According to one early A.I. pioneer: "You can either use this as an unfair advantage to grow your wealth, or you can let it ravage your retirement savings. There's no middle option."
Financials
| Curr Year EPS Estimate | 18.45 |
| Next Quarter EPS Estimate | 6.14 |
| Profit Margin | 0.30 |
| Return on Assets | 0.11 |
| Return on Equity | 0.34 |
| Revenue | 13,444,599,808 |
| Earnings Per Share | 24.80 |
| Revenue Per Share | 83.56 |
| Gross Profit | 11,639,400,000 |
| Quarterly Revenue Growth | -0.22 |
General
| Name | Biogen Inc |
| Ticker | BIIB |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers-General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 9,100 |
About Biogen Inc
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases worldwide. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an etanercept biosimilar referencing ENBREL; IMRALDI, an adalimumab biosimilar referencing HUMIRA; and FLIXABI, an infliximab biosimilar referencing REMICADE. In addition, the company offers RITUXAN for treating non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL), rheumatoid arthritis, two forms of ANCA-associated vasculitis, and pemphigus vulgaris; RITUXAN HYCELA for non-Hodgkin's lymphoma and CLL; GAZYVA to treat CLL and follicular lymphoma; and OCREVUS for treating relapsing MS and primary progressive MS; and other anti-CD20 therapies. Further, it develops BIIB061, BIIB091, and BIIB107 for MS and neuroimmunology; Aducanumab, BAN2401, BIIB092, BIIB076, and BIIB080 to treat Alzheimer's disease and dementia; BIIB067, BIIB078, BIIB105, BIIB100, and BIIB110 to treat neuromuscular disorders; BIIB124, BIIB094, BIIB118, BIIB101, and BIIB122 for treating Parkinson's disease and movement disorders; BIIB111 and BIIB112 to treat ophthalmology related diseases; BIIB125 and BIIB104 for treating neuropsychiatry; Dapirolizumab pegol and BIIB059 to treat immunology related diseases; BIIB093 and TMS-007 to treat acute neurology; BIIB074 and BIIB095 for neuropathic pain; and SB11 and SB15 biosimilars, which are under various stages of development. The company offers products through its sales force and marketing groups. It has collaboration and license agreements with Acorda Therapeutics, Inc.; Alkermes Pharma Ireland Limited; Bristol-Myers Squibb Company; Eisai Co., Ltd.; Genentech, Inc.; Neurimmune SubOne AG; and Ionis Pharmaceuticals, Inc. The company was founded in 1978 and is headquartered in Cambridge, Massachusetts.
Earnings
Donald Trump Could Still Win Even If He Loses In Supreme Court Over Presidential Immunity Claim
Former President Donald Trump could see a strategic victory in his Supreme Court case, even if the court dismisses his claim regarding presidential immunity.
Key Nvidia, Apple Supplier TSMC To Receive $6.6B From US Government For Arizona Plant
The funding, a part of the U.S. CHIPS and Science Act, will bolster TSMC's over $65 billion investment in three advanced fabrication plants in Phoenix, Arizona.
The No. 1 Crypto for 2024 - Ad
We're entering the final crypto bull run, and 2024 will be your last chance to ever get rich from crypto. These five tiny cryptos are believed to create generational wealth over the next 12 months. $30 trillion is poised to funnel into the crypto markets thanks to a new government regulation just signed.
Fed's High-Interest Rate Policy Spurs Debate Over Economic Impact: 'This Is The Path Of A Potential Problem...'
The Federal Reserve's recent decision to maintain high interest rates for an extended period has sparked a debate over its potential impact on the U.S. economy. Despite the ongoing economic stability, the Fed's stance has raised concerns among investors and the general public.
Russian Missile Strike In Ukraine Injures Six, Damages Civilian Infrastructure
A Russian missile strike has caused severe damage to civilian and railway infrastructure in Ukraine's Cherkasy region, injuring six people.
CRITICAL May 1st Warning - Ad
Jason Bodner is going public today with an urgent new warning. He believes the most popular investment of 2024 is set to pop... And it could all start just days from now. This has NOTHING to do with A.I. stocks... It has NOTHING to do with crypto currency... And it has NOTHING to do with high-flying tech stocks. Instead, this corner of the market you likely have cash parked in has swelled to nearly $6 trillion.
Courtroom Appearances By These Two Members Of Donald Trump's Family Could Help Him In Hush-Money Trial, Say Experts
As former President Donald Trump faces a hush-money trial, legal experts suggest that the presence of his wife, former First Lady Melania Trump, and daughter, Ivanka Trump, could significantly influence t
GM Unveils Plans For Autonomous Driving Unit Cruise Relaunch After Hiatus, Expects $1.7B In Expenses
Detroit-based automaker General Motors on Tuesday detailed its plans for the relaunch of its autonomous driving unit Cruise, months after it paused operations owing to the involvement of one of its robotaxis in an accident in San Francisco.
Election Shock on August 19th? - Ad
In less than 258 days, I expect the biggest presidential election shock since 1968. Forget about Donald Trump... And forget about Joe Biden... Instead, I believe the unexpected is barreling toward America. And I believe the aftermath will transform this country forever.
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
PARIS (AP) — U.S. track and field athletes have around four dozen pieces to choose from when assembling their uniforms at the Olympics. The one grabbing the most attention is a high-cut leotard that barely covers the bikini line and has triggered debate between those who think it is sexist and others who argue they don't need the internet to make sure they have good uniforms.
US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platforms, Inc.’s (NASDAQ:META)
America's Final Republican President - Ad
Louis Navellier believes Donald J. Trump could go down as America's last Republican president. But NOT for the reasons you may think... If he's right, the soul of this country will change forever...
Nike's Sneaker Coup: Reportedly Nears Lucrative Deal With Basketball Sensation Caitlin Clark
Nike reportedly strikes a game-changing endorsement pact with basketball prodigy Caitlin Clark, ahead of her WNBA debut in May. The rising star, freshly picked by the Indiana Fever, is set to headline her own signature shoe line under Nike, echoing the brand's commitment to nurturing young talent.
'Should Have Sold Our Entire $TSLA Position,' Says Fund Manager, Following EV Giant's Coordinated Global Price Cuts Over Weekend
Gary Black suggests Tesla's configurator price cuts won't benefit the company, as rivals are likely to match them, following Tesla's global EV price reductions.
Bitcoin Gained 164% in 2023 but Crypto Millionaire Abandoned It for This - Ad
A certain crypto genius and millionaire has been praising Bitcoin since it was trading for $61. Even though it gained 164% last year, he's now recommending a different cryptocurrency. In fact, he's betting his own money on and buying it like crazy.
Cathie Wood's Ark Buys Roku, Palantir And $1M Worth Of Stock In This Healthcare Company
Roku is the third biggest holding of Ark's flagship ARKK exchange-traded fund.
What's Going On With Freeport-McMoRan Shares Today?
Freeport-McMoRan reports Q1 FY24 results, beats expectations in revenue and adjusted EPS. Copper and gold sales increase.
New Video: What A.I. Means for Cancer (And Other Diseases) - Ad
I urge you to check it out before we take the video down. You'll discover how AI discovered a new treatment in only 30 days, why Big Pharma signed over $3 billion in deals with one AI-biotech, and why Bill Gates and billionaire Steve Cohen own over 10% of this company.
Over $1M Bet On This Consumer Cyclical Stock? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed lower on Friday, there were a few notable insider trades.
Former Trump Attorney Vows To Cease Public Criticism Of Ex-President Until Hush-Money Trial Is Over
Legal experts voiced concerns about Cohen's ongoing public commentary on the case.
The Mysterious Tale of "America's No. 1 Retirement Stock" - Ad
This factory of 53,000 employees, in Burbank, CA, was camouflaged to look like a sleepy suburb (with the help of artists, set designers, and painters from nearby Hollywood movie studios). The mysterious company behind this disappearing act is now being called "America's No. 1 Retirement Stock".
An NPR editor who wrote a critical essay on the company has resigned after being suspended
NEW YORK (AP) — A National Public Radio editor who wrote an essay criticizing his employer for promoting liberal views resigned on Wednesday, a day after it was revealed that .
8 years after the National Enquirer's deal with Donald Trump, the iconic tabloid is limping badly
NEW YORK (AP) — Catch and kill. Checkbook journalism. Secret deals. Friends helping friends.
The Next Nvidia? - Ad
Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet...but in the next 6 months that's all they'll talk about.
Why Personal Products Major Unilever Shares Are Rising Today
Unilever's Q1 FY24 earnings showed revenue growth and strong performance from its Power Brands, Beauty & Wellbeing, Personal Care, and Home Care segments.
'Not Something Steve Jobs Would Probably Do': Gurman Says Apple Should Go Against The Grain And Lower iPhone's Price Point
Apple is expected to see a year-over-year sales decline in the March quarter, as both its flagship iPhone and the crucial China market are facing challenges.
Shhh! This Is One Great Coin... - Ad
Shhh! I truly believe this crypto could be one of the top earning cryptos of all time... In fact, in the coming bull run... this one coin could have the potential to bank 10x... 50x... and even 100x.
The world's largest 3D printer is at a university in Maine. It just unveiled an even bigger one
ORONO, Maine (AP) — The world’s largest 3D printer has created a house that can cut construction time and labor. An even larger printer unveiled on Tuesday may one day create entire neighborhoods.
EXCLUSIVE: Industry Leaders Predict How The Bitcoin Halving Impacts Prices And Mining
As the cryptocurrency world braces for the upcoming Bitcoin halving, industry leaders told Benzinga they expect significant market shifts, voicing concerns over mining centralization.
"America's No. 1 Retirement Stock" (Name Inside) - Ad
According to the former Goldman Sachs VP -- who wrote a best-selling book on retirement -- one single stock stands head-and-shoulders above all others. And it should be the cornerstone of your portfolio. Have you heard of it?
FTC sends $5.6 million in refunds to Ring customers as part of video privacy settlement
NEW YORK (AP) — The Federal Trade Commission is sending more than $5.6 million in refunds to consumers as part of a settlement with Amazon-owned Ring, which was charged with failing to protect private video footage from outside access.
Oil sprays from an ANA flight carrying 213 people as it lands in northern Japan
TOKYO (AP) — Oil sprayed from an All Nippon Airways plane as it landed Wednesday at Shin Chitose airport in northern Japan, but none of the 213 people on board was injured, officials said.
Crypto Reboot Finally Makes An 8,788% Return Possible [NOT Bitcoin] - Ad
A crypto millionaire is revealing that a different cryptocurrency is going to do even better... It's not simply "buy the dip." Instead, it's a strategy that James learned during the dot com stock market crash. Not only has this strategy worked in a crash... it needs a crash to work best.
Shiba Inu Army Cheers As Burn Rate Soars 172%, Price Rebounds
Dogecoin killer Shiba Inu (CRYPTO: SHIB) has experienced a significant surge in its burn rate, increasing by an impressive 172%.
Honda planning to expand its electric vehicle efforts in Canada, Toyota expands in Indiana
Honda plans to invest $11 billion, with the help of joint venture partners, to build out its electric vehicle efforts in Canada as it prepares for future demand in North America for the automobiles.
The No. 1 AI Stock of 2024 (Not Nvidia) - Ad
It's not Nvidia, Meta Platforms, Alphabet, or Amazon. But thanks to a recent major deal, an under-the-radar stock could become the No. 1 winner of the AI boom. "This company just teamed up with one of the biggest power players in the AI industry... yet you can still buy it for just one-twelfth the price of Nvidia -- the time to buy is NOW," says Marc Chaikin.
Why Media Company Omnicom Shares Are Trading Higher Premarket Today
Omnicom Group reported 5.4% revenue growth, with organic growth of 4.0%. Adjusted EPS beat expectations.
First major attempts to regulate AI face headwinds from all sides
DENVER (AP) — Artificial intelligence is helping decide which Americans get the job interview, the apartment, even medical care, but the to reign in bias in AI decision making are facing headwinds from every direction.
What Should You Be Doing To "A.I.-Proof" Your Retirement? - Ad
A.I. is creeping into every aspect of our daily lives... According to billion-dollar fund manager Louis Navellier, it's never been more important to A.I.-proof your wealth. He lays out three simple steps to take ASAP in his latest video.
Remnants of bird flu virus found in pasteurized milk, FDA says
The U.S. Food and Drug Administration said Tuesday that samples of pasteurized milk had tested positive for remnants of the bird flu virus that has infected dairy cows.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.